國立虎尾科技大學 |

Uncertainty in Pharmacology = Epistemology, Methods, and Decisions /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Uncertainty in Pharmacology/ edited by Adam LaCaze, Barbara Osimani.
其他題名:	Epistemology, Methods, and Decisions /
其他作者:	LaCaze, Adam.
面頁冊數:	XIII, 470 p. 48 illus.online resource. :
Contained By:	Springer Nature eBook
標題:	Medicine—Philosophy. -
電子資源:	https://doi.org/10.1007/978-3-030-29179-2
ISBN:	9783030291792

Uncertainty in Pharmacology = Epistemology, Methods, and Decisions /
Uncertainty in PharmacologyEpistemology, Methods, and Decisions /[electronic resource] :edited by Adam LaCaze, Barbara Osimani. - 1st ed. 2020. - XIII, 470 p. 48 illus.online resource. - Boston Studies in the Philosophy and History of Science,3380068-0346 ;. - Boston Studies in the Philosophy and History of Science,307.

Part I. Epistemology -- 1. Defining Aspects of Mechanisms: Evidence-Based Mechanism (Evidence for a Mechanism), Mechanism-Based Evidence (Evidence from a Mechanism), and Mechanistic Reasoning -- 2. Causal Insights from Failure: Post-Marketing Risk Assessment of Drugs as aWay to Uncover Causal Mechanisms -- 3. Extrapolating from Model Organisms in Pharmacology -- 4. "Mechanistic Versus Statistical Extrapolation in Preclinical Research in Psychiatry: Challenging the Received View" -- 5. Analogy-Based Inference Patterns in Pharmacological Research -- 6. "In Silico Clinical Trials: a Possible Response to Complexity in Pharmacology" -- 7. "Uncertainty in Drug Discovery: Strategies, Heuristics and Technologies" -- 8. “Caught in the Amber”: a Sketch of Chemical Underdetermination -- Part II. Methods -- 9. A Millian Look at the Logic of Clinical Trials -- 10. "Learning by Difference: Placebo Effects and Specific Efficacy in Pharmacological RCTs" -- 11. "An Evidence-Hierarchical Decision Aid for Ranking in Evidence-Based Medicine" -- 12. "Assessing Drug Safety Assessment: Metformin Associated Lactic Acidosis" -- 13. Robust Biomarkers: Methodologically Tracking Causal Processes in Alzheimer’s Measurement -- 14. "Modelling Individual Response to Treatment and its Uncertainty: a Review of Statistical Methods and Challenges for Future Research" -- Part III. Decisions -- 15. Values in Pharmacology -- 16. "Humbug, the Council of Pharmacy and Chemistry, and the Origin of “the Blind Test” of Therapeutic Efficacy" -- 17. On the Normative Foundations of Pharmaceutical Regulation -- 18. After Disclosure -- 19. Sex, Drugs, and how to Deal with Criticism—The Case of Flibanserin.

This volume covers a wide range of topics concerning methodological, epistemological, and regulatory-ethical issues around pharmacology. The book focuses in particular on the diverse sources of uncertainty, the different kinds of uncertainty that there are, and the diverse ways in which these uncertainties are (or could be) addressed. Compared with the more basic sciences, such as chemistry or biology, pharmacology works across diverse observable levels of reality: although the first step in the causal chain leading to the therapeutic outcome takes place at the biochemical level, the end-effect is a clinically observable result—which is influenced not only by biological actions, but also psychological and social phenomena. Issues of causality and evidence must be treated with these specific aspects in mind. In covering these issues, the book opens up a common domain of investigation which intersects the deeply intertwined dimensions of pharmacological research, pharmaceutical regulation and the related economic environment. The book is a collective endeavour with in-depth contributions from experts in pharmacology, philosophy of medicine, statistics, scientific methodology, formal and social epistemology, working in constant dialogue across disciplinary boundaries.

ISBN: 9783030291792

Standard No.: 10.1007/978-3-030-29179-2doiSubjects--Topical Terms:

1253490
Medicine—Philosophy.

LC Class. No.: R723-723.7

Dewey Class. No.: 610.1

Uncertainty in Pharmacology = Epistemology, Methods, and Decisions /
LDR:04444nam a22004095i 4500 001 1025286
003 DE-He213
005 20200704040654.0
007 cr nn 008mamaa
008 210318s2020 gw | s |||| 0|eng d
020 $a 9783030291792 $9 978-3-030-29179-2
024 7 $a 10.1007/978-3-030-29179-2 $2 doi
035 $a 978-3-030-29179-2
050 4 $a R723-723.7
072 7 $a HP $2 bicssc
072 7 $a MED050000 $2 bisacsh
072 7 $a QD $2 thema
082 0 4 $a 610.1 $2 23
245 1 0 $a Uncertainty in Pharmacology $h [electronic resource] : $b Epistemology, Methods, and Decisions / $c edited by Adam LaCaze, Barbara Osimani.
250 $a 1st ed. 2020.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a XIII, 470 p. 48 illus. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Boston Studies in the Philosophy and History of Science, $x 0068-0346 ; $v 338
505 0 $a Part I. Epistemology -- 1. Defining Aspects of Mechanisms: Evidence-Based Mechanism (Evidence for a Mechanism), Mechanism-Based Evidence (Evidence from a Mechanism), and Mechanistic Reasoning -- 2. Causal Insights from Failure: Post-Marketing Risk Assessment of Drugs as aWay to Uncover Causal Mechanisms -- 3. Extrapolating from Model Organisms in Pharmacology -- 4. "Mechanistic Versus Statistical Extrapolation in Preclinical Research in Psychiatry: Challenging the Received View" -- 5. Analogy-Based Inference Patterns in Pharmacological Research -- 6. "In Silico Clinical Trials: a Possible Response to Complexity in Pharmacology" -- 7. "Uncertainty in Drug Discovery: Strategies, Heuristics and Technologies" -- 8. “Caught in the Amber”: a Sketch of Chemical Underdetermination -- Part II. Methods -- 9. A Millian Look at the Logic of Clinical Trials -- 10. "Learning by Difference: Placebo Effects and Specific Efficacy in Pharmacological RCTs" -- 11. "An Evidence-Hierarchical Decision Aid for Ranking in Evidence-Based Medicine" -- 12. "Assessing Drug Safety Assessment: Metformin Associated Lactic Acidosis" -- 13. Robust Biomarkers: Methodologically Tracking Causal Processes in Alzheimer’s Measurement -- 14. "Modelling Individual Response to Treatment and its Uncertainty: a Review of Statistical Methods and Challenges for Future Research" -- Part III. Decisions -- 15. Values in Pharmacology -- 16. "Humbug, the Council of Pharmacy and Chemistry, and the Origin of “the Blind Test” of Therapeutic Efficacy" -- 17. On the Normative Foundations of Pharmaceutical Regulation -- 18. After Disclosure -- 19. Sex, Drugs, and how to Deal with Criticism—The Case of Flibanserin.
520 $a This volume covers a wide range of topics concerning methodological, epistemological, and regulatory-ethical issues around pharmacology. The book focuses in particular on the diverse sources of uncertainty, the different kinds of uncertainty that there are, and the diverse ways in which these uncertainties are (or could be) addressed. Compared with the more basic sciences, such as chemistry or biology, pharmacology works across diverse observable levels of reality: although the first step in the causal chain leading to the therapeutic outcome takes place at the biochemical level, the end-effect is a clinically observable result—which is influenced not only by biological actions, but also psychological and social phenomena. Issues of causality and evidence must be treated with these specific aspects in mind. In covering these issues, the book opens up a common domain of investigation which intersects the deeply intertwined dimensions of pharmacological research, pharmaceutical regulation and the related economic environment. The book is a collective endeavour with in-depth contributions from experts in pharmacology, philosophy of medicine, statistics, scientific methodology, formal and social epistemology, working in constant dialogue across disciplinary boundaries.
650 0 $a Medicine—Philosophy. $3 1253490
650 0 $a Medical ethics. $3 559096
650 1 4 $a Philosophy of Medicine. $3 671737
650 2 4 $a Theory of Medicine/Bioethics. $3 671734
700 1 $a LaCaze, Adam. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1321531
700 1 $a Osimani, Barbara. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1321532
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030291785
776 0 8 $i Printed edition: $z 9783030291808
776 0 8 $i Printed edition: $z 9783030291815
830 0 $a Boston Studies in the Philosophy and History of Science, $x 0068-0346 ; $v 307 $3 1255348
856 4 0 $u https://doi.org/10.1007/978-3-030-29179-2
912 $a ZDB-2-REP
912 $a ZDB-2-SXPR
950 $a Religion and Philosophy (SpringerNature-41175)
950 $a Philosophy and Religion (R0) (SpringerNature-43725)